Overview

Safety and Efficacy of SA09012 in Asthma

Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
Clinical Study to Evaluate the Efficacy, Dose-response and Safety of SA09012 in Bronchial Asthma Patients
Phase:
Phase 2
Details
Lead Sponsor:
SamA Pharmaceutical Co., Ltd